Progesterone-releasing intravaginal device

  • From a merge: This is a redirect from a page that was merged into another page. This redirect was kept in order to preserve the edit history of this page after its content was merged into the content of the target page. Please do not remove the tag that generates this text (unless the need to recreate content on this page has been demonstrated) or delete this page.
    • For redirects with substantive page histories that did not result from page merges use {{R with history}} instead.

Clinical uses of PRID

[1]
  1. Synchronisation of oestrus in conjunction with prostaglandin[2][3] The PGF2α injection helps to ensure there is no residual CL and the potentially ovulating follicle has been held primed for less time, enhancing its viability.

Protocol – PRID for 9 days. PGF2α injection on days 5–8. Serve on observed oestrus or fixed time once at 56h or twice at 48h and 72h.

  1. Induction of oestrus in anoestrus cows[4]
  2. Treatment of follicular cysts
  3. Persistent ovarian follicles
  4. Improve oocyte quality
  5. Reduction of early embryonic death and improved fertility
  6. Treatment of repeat breeders
  7. Increased fertility in embryo transfer protocols

References

  1. ^ Reproduction in Cattle. A.R. Peters and P.J.H. Ball
  2. ^ Deletang et al. (2006). Efficacy of PRID with injection of PGF2a for synchronising oestrus in French dairy and beef cattle. World Biuatric Congress.
  3. ^ McPhee et al. (1983). Multiple use of progesterone releasing intravaginal devices for synchronisation of oestrus and ovulation in cattle. Australian Vet Journal, 60 pp. 40–43
  4. ^ Tjondronegoro et al. (1987). Effects of progesterone intravaginal devices on synchronisation of oestrus in post-partum dairy cows. Journal of Dairy Sciences,70, pp. 2162–67